Cubist Systematic Strategies, LLC Intercept Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $921,887 - $1.73 Million	92,281 New	92,281 $1.71 Million
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $1.48 Million - $2.57 Million	-118,507 Reduced 52.47%	107,344 $1.44 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $1.26 Million - $1.74 Million	-108,317 Reduced 32.41%	225,851 $2.79 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $3.19 Million - $5.15 Million	261,412 Added 359.3%	334,168 $4.66 Million
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $1.47 Million - $2.56 Million	-130,495 Reduced 64.2%	72,756 $1.01 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $1.19 Million - $1.59 Million	89,247 Added 78.28%	203,251 $3.31 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $268,178 - $366,773	18,780 Added 19.72%	114,004 $1.86 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $164,076 - $258,556	12,631 Added 15.29%	95,224 $1.41 Million
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $558,322 - $884,793	-36,114 Reduced 30.42%	82,593 $1.65 Million
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $530,569 - $1.04 Million	-27,448 Reduced 18.78%	118,707 $2.74 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $2.66 Million - $4.61 Million	108,600 Added 289.18%	146,155 $3.61 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $984,012 - $1.35 Million	25,173 Added 203.3%	37,555 $1.56 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $966,082 - $1.9 Million	-20,687 Reduced 62.56%	12,382 $593,000
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $1.2 Million - $2.95 Million	-24,842 Reduced 42.9%	33,069 $2.08 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $1.79 Million - $3.88 Million	31,266 Added 117.34%	57,911 $7.18 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $1.01 Million - $1.39 Million	17,265 Added 184.06%	26,645 $1.77 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $729,482 - $1.13 Million	9,380 New	9,380 $746,000
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $45,915 - $60,340	-500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $42,895 - $63,230	500 New	500 $50,000
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $17,160 - $24,501	-286 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $179,986 - $229,591	-3,414 Reduced 92.27%	286 $18,000
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $175,589 - $219,516	-3,017 Reduced 44.92%	3,700 $216,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $382,936 - $797,643	6,717	6,717 $390,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account